2012 Provisional Classification Criteria for Polymyalgia Rheumatica: a European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
Overview
Authors
Affiliations
The objective of this study was to develop European League Against Rheumatism/American College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients with new-onset PMR and 169 non-PMR comparison subjects with conditions mimicking PMR. A scoring algorithm was developed based on morning stiffness >45 minutes (2 points), hip pain/limited range of motion (1 point), absence of rheumatoid factor and/or anti-citrullinated protein antibody (2 points), and absence of peripheral joint pain (1 point). A score ≥4 had 68% sensitivity and 78% specificity for discriminating all comparison subjects from PMR. The specificity was higher (88%) for discriminating shoulder conditions from PMR and lower (65%) for discriminating RA from PMR. Adding ultrasound, a score ≥5 had increased sensitivity to 66% and specificity to 81%. According to these provisional classification criteria, patients ≥50 years old presenting with bilateral shoulder pain, not better explained by an alternative pathology, can be classified as having PMR in the presence of morning stiffness >45 minutes, elevated C-reactive protein and/or erythrocyte sedimentation rate, and new hip pain. These criteria are not meant for diagnostic purposes.
Incidence Trends of Rheumatoid Arthritis in Korea for 11 Years (2006-2017).
Lee H, Lee S, Lim H, Kim H, Kim R, Cheon Y Clin Pract. 2024; 14(6):2475-2483.
PMID: 39585021 PMC: 11587020. DOI: 10.3390/clinpract14060193.
Irani L, Bou Karroum M, Chehab Y, Abi Saad N, Al Dailaty A, Husni R Medicine (Baltimore). 2024; 103(43):e40204.
PMID: 39470514 PMC: 11521047. DOI: 10.1097/MD.0000000000040204.
[News on the imaging of large vessel vasculitis].
Schafer V, Petzinna S, Schmidt W Z Rheumatol. 2024; 83(10):800-811.
PMID: 39271483 DOI: 10.1007/s00393-024-01565-0.
Heras-Recuero E, Blazquez-Sanchez T, Landaeta-Kancev L, Martinez de Bourio-Allona M, Torres-Rosello A, Rengifo-Garcia F Diagnostics (Basel). 2024; 14(14).
PMID: 39061676 PMC: 11275637. DOI: 10.3390/diagnostics14141539.
Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study.
Fedorinova E, Bulanov N, Meshkov A, Borodin O, Smitienko I, Chachilo E Dokl Biochem Biophys. 2024; 517(1):250-258.
PMID: 39002010 DOI: 10.1134/S1607672924700984.